The aim of this standard operating procedure is to provide asymptomatic testing, as required by a clinically led risk-based approach, to elective care patients using primarily lateral flow devices (LFDs), or polymerase chain reaction (PCR) tests if clinically recommended, from 1 April 2022. This will enable patients on elective care pathways to test as advised in advance of being admitted for an elective care procedure, ensuring safe care for the patient, reducing the risk of nosocomial transmission, and supporting the delivery of elective recovery.